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Abstract of thesis presented to the Senate ofUniversiti Putra Malaysia in fulfilment
of the requirement for the degree of Master of Science
EFFECTS OF "JIN BATU" (STROBILANTHES CRlSPUS) EXTRACT ON
SERUM LIPID PROFILE AND ANTIOXIDANT STATUS OF
HYPERCHOLESTEROLEMIA-INDUCED RABBITS
By
NURHAFZAN ANIS BINTI ISMAIL
February 2007
Chairman: Professor Maznah Ismail, PhD
Faculty : Medicine and Health Sciences
Hypocholesterolemic, anti-atherogenic, toxicity effects and changes in the antioxidant
status of Strobilanthes crispus extract (SCE) in atherogenically induced animal model
were studied. As much as, 58.05 ± 1.08% total dietary fiber (TDF), 54.61 ± 3.92%
insoluble dietary fiber (IDF) and 6.01 ± 0.82% soluble dietary fibers (SDF) was found
in the Strobilanthes crispus (SC) ground, dried leaves (AOAC method). At
concentration of 0.32-5.12 mg/ml, SCE showed 3.76 ± 7.45% to 56.72 ± 2.49%
scavenging effect on 1,I-diphenyl-2-picrylhydrazyl (DPPH) radicals with ECso of 2.21
mg/ml. The total flavonoids content in SC fresh leaves and ground, dried leaves were
0.99 ± 0.04 % and 0.46 ± 0.06 %, respectively. Quercetin was found highest in SC
ground, dried leaves, followed by kaempferol, luteolin and rutin while kaempferol was
found highest in SCE, followed by quercetin, luteolin and rutin (HPLC method).
Twenty-four adult female New Zealand white rabbits (1.8-2.5 kg) were randomly
assigned into four groU!1S (n=6/group) and fed with normal diet; negative control (NC),
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0.25% high cholesterol diet (HCD); positive control (PC), 0.25% HCD + SCE (0.2% of
diet); SC and 0.25% HCD + simvastatin (SV) (20 mg/kg body weight); SV for 12
weeks. Food and water were given ad libitum. Blood samples were biweekly drawn for
serum lipid profiles, alanine amino transferase (ALT), gamma glutamic transpeptidase
(GGT), urea, creatinine, conjugated diene (CD), malondialdehyde (MDA) levels of
serum, liver, kidney, heart and brains. After being killed, ascending aorta, liver, kidney
and heart tissue specimens were excised immediately and prepared for the
histopathological studies. PC group showed significantly increased (p<0.05) TC, LDL
and HDL levels, HDL/TC ratio, LDL/HDL ratio, atherogenic index, CD levels, serum,
heart, liver and kidney MDA levels, and relative liver weight. Significantly (p<0.05)
elevated HDL and reduced kidney MDA levels were observed in SC group, while
significantly reduced (p<0.05) TC, LDL, heart, liver and serum MDA levels found in
SV group. Massive macrophages, foam cells and atheroma plaque formation were
detected, which slightly increased intima to media ratio and thickened the PC group's
aorta. Moderate to fairly intense lymphocyte infiltration, slight macrovesicular lipid
droplets, edematous hepatocytes, inconsistent binucleated cells and vacuolated
cytoplasm were found in PC group's liver. Significantly prevented (p<0.05) atheroma
plaque formation, both treatment groups showed lesser aortas' thickening, irregular
mild edematous hepatocytes, binucleated cells, vacuolated cytoplasm and lipid droplets
inhibition. Though mild lymphocyte infiltration was found in SV, such changes were
almost invisible in SC group. Briefly, SC plant may possess the hypocholesterolemic,
anti-atherogenic and hepatoprotective effect due to the antioxidative properties of
flavonoids, i.e. quercetin, kaempferol, luteolin, rutin and catechin.
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Kesan hipokoiesterolemik, anti-aterogenik, ketoksikan dan perubahan status antioksidan
ekstrak Strobilanthes crispus (SCE) terhadap model haiwan diaruh aterogenik dikaji.
Sebanyak 58.05 ± 1.08% serat diet jumlah (TDF), 54.61 ± 3.92% serat diet tak larut
(IDF) dan 6.01 ± 0.82% serat diet Iarut (SDF) telah diperolehi di dalam daun kering SC
terkisar (kaedah AOAC). Pada kepekatan 0.32-5.12 mg/mI, SCE telah menunjukkan
sebanyak 3.76 ± 7.45% hingga 56.72 ± 2.49% kesan perencatan terhadap radikal 1,1-
difenil-2-pikrilhidrazil (DPPH) dengan ECso=2.21 mg/m!. Jumlah kandungan flavonoid
yang terdapat di dalam daun Strobilanthes crispus (SC) segar dan kering terkisar ialah
masing-masing sebanyak 0.99 ± 0.04% dan 0.46 ± 0.06%. Kuersetin didapati tertinggi
di dalam daun kering SC terkisar, diikuti oleh kemferol, Iuteolin dan rutin, manakala
kemferol didapati tertinggi di dalam ekstrak kasar SC diikuti oleh kuersetin, luteolin dan
rutin (kaedah HPLC). Sebanyak 24 ekor amab putih betina dewasa New Zea!and (1.8-
2.5 kg) telah dibahagikan secara rawak kepada empat kumpulan (n=6/kumpulan); dan
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diberikan diet normal; kawalan negatif (NC), 0.25% diet berkolesterol tinggi (HCD);
kawalan positif (PC), 0.25% HCD + SCE (0.2% daripada diet); SC dan 0.25% HCD +
simvastatin (20 mg/kg berat badan); SV, selama 12 minggu. Amab-amab tersebut diberi
makanan dan minuman tanpa halangan. Sampel darah diambil pada setiap dua minggu
bagi analisis profillipid, alanin aminotransferase (ALT), gamma glutamil transpeptidase
(GGT), urea, kreatinin, diene terkonjugat (CD) serum dan malondialdehid (MDA) di
dalam serum, hepar, ginjal, jantung dan otak. Setelah dibunuh, spesimen tisu aorta,
hepar, ginjal dan jantung diambil dengan segera dan disediakan bagi kajian
histopatologi. Kumpulan PC menunjukkan peningkatan kolesterol jumlah (TC),
lipoprotein berketumpatan rendah (LDL) dan nisbah lipoprotein berketumpatan tinggi
kepada kolesterol jumlah (HTR), nisbah LDL/HDL, indeks aterogenik, kepekatan MDA
serum, jantung, hepar dan ginjal, kepekatan CD serum serta berat hepar relatif yang
signifikan (p<0.05). Peningkatan paras lipoprotein berketumpatan tinggi (HDL) dan
juga pengurangan paras MDA ginjal secara signifikan (p<0.05) telah didapati oleh
kumpulan Sc. Manakala kumpulan SV menunjukkan kesan penurunan paras TC, LDL,
MDA jantung, hepar dan serum secara signifikan (p<0.05). Sejumlah besar makrofaj,
sel buih dan lesi aterosklerosis telah dikesan, yang meningkatkan nisbah intima
terhadap media dan menebalkan aorta kumpulan Pc. Penyerapan limfosit dan yang
sederhana ke agak padat, titisan kecil lipid makrovesikular, hepatosit beredema,
kehadiran sel dengan dua nukleus dan sitoplasma bervakuol yang tidak konsisten dilihat
pada kumpulan PC. Dengan percncatan pembentukan plak ateroma yang signifikan
(p<0.05), kedua-dua kumpulan rawatan menunjukkan aorta yang kurang menebal,
sedikit hepatosit beredema, sel dengan dua nukleus dan sitoplasma bervakuol yang tidak
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konsisten dan perencatan titisan lipid. Walaupun penyerapan limfosit yang rendah telah
dikesan di dalam kumpulan SV, perubahan tersebut hampir tidak kelihatan di dalam
kurnpulan SC. Kesimpulannya, tumbuhan SC mungkin memiliki cm-cm
hipokolesterolemik, anti-aterogenik dan perlindungan hepar disebabkan cm-cm
antioksidatif flavonoid, contohnya kuersetin, kemferol, luteolin dan rutin serta katekin.
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CHAPTER 1
INTRODUCTION
1.1 Research Background
The World Health Organization (WHO) attributes 12 million deaths a year worldwide to
cardiovascular diseases (CVD). The disease involves disorders of the blood circulation
system and pathological changes in blood vessels associated mainly with the heart and
brain (Cruez, 2005). Among the specific cardiovascular disease, ischaemic heart disease
(IHD), often called coronary heart disease (CHD), and ischaemic stroke (insufficient
blood flow to a region ofthe brain) accounted for the main causes ofmortality.
According to a study by Khoo et al. (1991), in 1950 CVD was the third biggest killer in
Malaysia. Twenty years later, the disease has emerged as the number one killer in
Malaysia. In this new millennium era, CVD remains as prevalent as ever. The disease
has been reported as the most deadly disease in developing countries (WHO Monica.
Project, 1988). The dietary pattern in these countries have become westernized after
rapid growth of their economies. For instance, according to a data from the Nutrition
Society of Malaysia, in 1961 Malaysians consumed 70% vegetables and 30% animal
products. However, in 1997 Malaysians were eating 45% vegetables and 55% animal
products. There has been an increase in the consumption of refined carbohydrates such
as simple sugars in coffee, cookies, cakes and increase in fats in the diet, especially
saturated fats from animal sources. As a result, the number of people suffering from
diet-related diseases such as obesity, diabetes, hypertension, CVD and various cancers
has increased significantly (Krauss et aI., 1998; Kritchevsky, 1995; Sabaratnam, 2003).
Atherosclerosis is the underlying disorder in the majority of patients with CVD.
Atherosclerosis refers to the build up of fatty material in the arterial wall, which leads to
narrowing of an artery with potential blockage. Elevated levels of plasma or serum low
density lipoprotein (LDL) cholesterol is associated with atherosclerosis (Linder, 1991;
Leys et al., 2002). It is now well established that statins (also known as HMG-CoA
Reductase inhibitors) are potent and effective but expensive drugs for treating
hypercholesterolemia. According to the Health Ministry of Malaysia (MOH),
expenditure to treat heart diseases increased from RM 226 millions in 1996 to RM 751
millions in 2003. The use of statins in the primary prevention of atherosclerosis alone
cost nearly RM 10 millions annually (Cruez, 2005). Apart from this, subsidy payments
for National Heart Institute (UN) to treat civil servants and poor patients rose from RM
31.3 million between September 1992 and August 1993 to RM 144.5 million between
September 2003 and August 2004. These statistics reflect the financial burden borne by
the Government due to CVD.
Coronary heart diseases increased from 27% of total cardiovascular deaths in 1985 to
30.5% in 2002 (Cruez, 2005). In 2003, cardiovascular diseases accounted for 120,295
admissions in government hospital or 7% of total admissions. From this, 5,162 were
terminal cases representing 14.2% of all terminal cases (MOH, 2003).
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Recently, the trend of going back to nature is getting popular in Malaysia and globally.
Demand for natural health supplements (e.g.: vitamins and herbal remedies) is
increasing since modern medicine and synthetic drugs have not been totally successful
in solving health problems such as cancer and heart disease. Despite the beneficial LDL
cholesterol lowering potential of statins, liver function test monitoring is required with
the statins treatment since statins is related with possible hepatic dysfunction, myopathy
together with muscle pain, tenderness or weakness. Therefore, the growing public alarm
about the hazards associated with excessive use of synthetic drugs has revived the
interest in the use of herbal medicines.
More Malaysians are taking active measures off illnesses and maintain good health by
taking supplements. There has also been an increasing worldwide recognition of the
important role of traditional herbal medicine. For example, the WHO promotes the use
of herbal medicines for certain conditions such as arthritis, asthma, diabetes, stroke and
vaginitis (Natila, 2002). Locally, the Forest Research Institute of Malaysia (FRIM),
together with a private company is helping to upgrade the traditional medicine industry
and preserve trees and herbal plants with medicinal values.
The current global trend shows that herbal therapy enters the mainstream medicine as
being observed from 1970 to 2000 (Wazir, 2003). Herbs and medicinal plants are
mainly used for flavours and fragrance, biopcsticides, pharmaceutical and
nutraceuticals. Most of Malaysian pharmaceutical products are mainly analgesics,
antacids, diuretics, antibiotics and anti-histamines in the form of tablets, capsules, drops,
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